Press Releases

12345678910
ACES Q3 2025 Mortgage QC Industry Trends Report shows concentrated rise in critical defects as income and compliance findings increase
DENVER, Colo., Feb. 18, 2026 (SEND2PRESS NEWSWIRE) -- ACES Quality Management® (ACES), the leading provider of enterprise quality management and control software for the financial services industry, today announced the release of its quarterly ACES Mortgage QC Industry Trends Report covering Q3 2025. The report analyzes post-closing quality control data derived from the ACES Quality Management & Control® software.
Via Send2Press · February 18, 2026
Tratta Releases 2026 Reality Check Debt Collection Industry Report
BRAINERD, Minn., Feb. 18, 2026 (SEND2PRESS NEWSWIRE) -- Tratta announces the release of "The 2026 Reality Check: The Widening Gap Between Digital Ambition and Maturity," a new industry survey report examining how debt collection agencies, legal recovery firms, and original creditors are progressing in their digital transformation efforts.
Via Send2Press · February 18, 2026
Jenner’s Pond Introduces Spacious, Newly Designed Cottages Designed for How Older Adults Want to Live: Connected, Independent, and at Ease
WEST GROVE, Pa., Feb. 18, 2026 (SEND2PRESS NEWSWIRE) -- Jenner's Pond in Chester County, one of Simpson's Continuing Care Retirement Communities (CCRCs), offers spacious cottages with new finishes, designed for today's active, modern elders looking for alternatives or to upsize to a forever home. With up to 3,600 square feet of thoughtfully designed living space, the cottages provide an option to skip the condo phase and settle directly into a 62+ Life Plan Community.
Via Send2Press · February 18, 2026
The Calculator Generation: Raised On Buttons Now Freezes When Real Numbers Show Up In Life
“Students aren’t failing math — schools are failing them,” argues Dr. Kelly, pointing to a quiet but consequential shift in classrooms: the replacement of cognitive struggle with technological shortcuts. Where students once wrestled with numbers, patterns, and estimation, many now reach instantly for a calculator. The result, he contends, is not greater efficiency but diminished numerical confidence. Difficulty itself was never the problem; difficulty is what builds thinking. Remove it, and you remove the very process that develops reasoning.
Via Get News · February 18, 2026
Best Sex Therapist in Beverly Hills, CA | Creating Change LA Offering Specialized Sex Therapy for Couples and Individuals
Creating Change LA in Beverly Hills, CA offers specialized sex therapy for couples and individuals seeking expert, evidence-based support from the best sex therapists delivering personalized, transformative therapeutic care to improve intimacy and connection.
Via Press Release Distribution Service · February 18, 2026
Mining Sector Leads Unprecedented Market Cap Surge on the 2026 TSX Venture 50(TM)
Toronto, Ontario--(Newsfile Corp. - February 18, 2026) - TSX Venture Exchange (TSXV) today announced the 2026 TSX Venture 50, an...
Via Newsfile · February 18, 2026
From Seoul's Global K-Wave to Web3 Leadership: Datavault AI and TBURN Chain Align K-Pop, Esports, and Korean Cultural Exports with Enterprise-Grade Data Asset Infrastructure and Tokenized Real World Assets
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 18, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today announced the execution of a collaboration agreement with TBURN Chain Foundation ("TBURN"), a high-performance blockchain infrastructure platform.
Via ACCESS Newswire · February 18, 2026
Habib Coudsi Leads COUDICAR's Expansion of CityCar Rental Services in Montreal with Customer First Mobility Approach
MONTREAL, WI / ACCESS Newswire / February 18, 2026 / COUDICAR, a growing provider of urban transportation solutions, has announced continued expansion of its services across Montreal under the leadership of Habib Coudsi. As demand for flexible vehicle access increases across major Canadian cities, the company is strengthening its citycar rental operations while reinforcing its reputation for reliability and accessibility.
Via ACCESS Newswire · February 18, 2026
Glucose Monitoring Device Market Forecast 2026-2036: Global Market to Reach USD 49.3 Billion by 2036 at 10.6% CAGR
According to Future Market Insights (FMI), the shift from traditional fingerstick methods to advanced continuous glucose monitoring (CGM) systems is redefining diabetes management in both clinical and home settings.
Via ACCESS Newswire · February 18, 2026
Iridium Development Inc. Announces Strong Q4 2025 Results and Expanding Luxury Home Pipeline Across Florida
Florida luxury home builder reports $23 million in sales, continued growth in custom home construction, and client-first transparency.
Via ACCESS Newswire · February 18, 2026
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license application for mRNA-1010 will proceed to review
Via ACCESS Newswire · February 18, 2026
TRU Executes Joint Venture Agreement Governing Its 51% interest in the Staghorn Property at Golden Rose
TORONTO, ON / ACCESS Newswire / February 18, 2026 / TRU Precious Metals Corp. (TSXV:TRU)(FSE:706) ("TRU" or the "Company") is pleased to announce that a Joint Venture Agreement ("JVA") that regulates the 51%/49% Joint Venture ("JV") arrangement on the Staghorn Property between the Company and Quadro Resources Ltd. ("Quadro") has been executed by the parties.
Via ACCESS Newswire · February 18, 2026
Elixr Debuts Careconscious, Formalizes Caregiving as a Measurable Business Strategy and Names Global HR Executive Elle Lebourg Co-Founder
Together, the workforce solution and the appointment of a Managing Partner accelerate the company's mission to make caregiving risk visible and actionable across organizations.
Via ACCESS Newswire · February 18, 2026
AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market
GARDEN GROVE, CA / ACCESS Newswire / February 18, 2026 / AQP ONE Inc., a U.S.-based health technology company founded by Vietnamese refugee entrepreneur, engineer, and University of Minnesota-trained chemist Tracy (Trang) Nguyen, today announced the launch of JBA AICare™, a physiological intelligence system designed to help individuals understand their health earlier and more continuously.
Via ACCESS Newswire · February 18, 2026
Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance
Altria Group, Inc. (Altria) (NYSE: MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Altria’s Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations.
By Altria Group, Inc. · Via Business Wire · February 18, 2026
TASKING Delivers Advanced Worst-Case Timing Coupling Analysis and Mitigation for Multicore Designs
TASKING, a global leader in high-performance embedded software development tools, today announced enhancements to its unified toolchain that provide greater in-depth timing analysis of real-time, multicore embedded systems. With the integration of TASKING’s compiler technology, BlueBox debuggers, winIDEA IDE, and the LDRA tool suite, developers can more accurately assess complex timing issues such as worst-case execution time (WCET) as outlined by industry standards. By accelerating and simplifying complex timing coupling analysis, TASKING helps OEMs reduce the risks and costs associated with certifying mission-critical multicore systems, including applications in aerospace, automotive, industrial, and robotics such as collaborative robots (cobots).
By TASKING · Via Business Wire · February 18, 2026
Utz Brands Highlights Long Term Strategy and Differentiated Growth at 2026 CAGNY Conference
Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded Salty Snacks and a small-cap value Staples equity, will discuss its strategies and long-term growth targets today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference. Chief Executive Officer, Howard Friedman, and EVP and Chief Financial Officer, BK Kelley, will outline how the Company plans to deliver sustainable growth and acceleration of free cash flow as the Company exits a capital-intensive transformation stage.
By Utz Brands, Inc. · Via Business Wire · February 18, 2026
Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast
Regulatory News:
By Philip Morris International · Via Business Wire · February 18, 2026
Perion Reports Fourth Quarter Results
Perion Network Ltd. (NASDAQ and TASE: PERI), an advanced technology leader solving for the complexities of digital advertising through AI-native execution infrastructure, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
By Perion Network Ltd. · Via Business Wire · February 18, 2026
SSR Mining Issues Notice of Redemption for Convertible Notes
SSR Mining Inc. (Nasdaq/TSX: SSRM) ("SSR Mining" or the “Company") announces that it has issued a notice of redemption (the “Redemption Notice”) for its $230,000,000 original aggregate principal amount of its 2.50% Convertible Senior Notes due 2039 (the “Notes”). There is currently $227,495,000 aggregate principal of Notes outstanding.
By SSR Mining Inc. · Via Business Wire · February 18, 2026
ICR Appoints Sukanti Ghosh as Partner, International Strategy & Markets
ICR, a leading strategic communications and advisory firm, today announced the appointment of Sukanti Ghosh as Partner, International Strategy & Markets, effective February 2, 2026.
By ICR · Via Business Wire · February 18, 2026
BETA Technologies to Announce Fourth Quarter & Full Year 2025 Results on March 9, 2026
BETA Technologies, Inc. (NYSE: BETA) (“BETA” or “the Company”), an electric aerospace company, today announced it will release its financial results for the fourth quarter and full year 2025 before the market opens on March 9, 2026. The Company will also host a live webcast beginning at 8:30 a.m. ET to discuss the results.
By BETA Technologies, Inc. · Via Business Wire · February 18, 2026
Insulet Reports Fourth Quarter and Full Year 2025 Results
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months and full year ended December 31, 2025.
By Insulet Corporation · Via Business Wire · February 18, 2026
LCI Industries Reports Fourth Quarter and Full Year Financial Results
LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported fourth quarter and full year 2025 results.
By LCI Industries · Via Business Wire · February 18, 2026
Global Payments Announces Board Appointment
Global Payments Inc. (NYSE: GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced the appointment of Vivek Sankaran as a new independent director to the company’s Board of Directors, effective February 19, 2026.
By Global Payments Inc. · Via Business Wire · February 18, 2026
Docebo Inc. Provides Update on Substantial Issuer Bid
Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, today provided an update on its previously announced substantial issuer bid (the “Offer”) under which the Company will offer to repurchase for cancellation up to US$60,000,000 of its outstanding common shares (“Common Shares”) at a price of US$20.40 per Common Share.
By Docebo Inc. · Via Business Wire · February 18, 2026
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the successful completion of Type B meetings with the U.S. Food and Drug Administration (FDA or the Agency) regarding its planned upcoming biologics license application (BLA) submission for tralesinidase alfa enzyme replacement therapy (TA-ERT).
By Spruce Biosciences, Inc. · Via Business Wire · February 18, 2026
Hyliion's KARNO Core Technology Successfully Completes Diesel Fuel Operation, Unlocking New Markets and Enhancing Energy Resiliency
Hyliion Holdings Corp. (NYSE American: HYLN), a developer of sustainable electricity-producing technology, today announced the successful operation of its full KARNO™ Core system on diesel fuel. This achievement marks a significant milestone towards the commercialization of the KARNO solution, confirming its operational effectiveness on liquid fuel in addition to its previously validated portfolio of gaseous fuels. During operation at the company’s Cincinnati, Ohio facility, the KARNO system successfully exported power to the grid while meeting stringent Tier 4 Final (T4F) emission requirements without the need for after-treatment systems.
By Hyliion Holdings Corp. · Via Business Wire · February 18, 2026
Infinity Natural Resources Appoints Thomas Marchetti as Vice President of Investor Relations
Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) today announced the appointment of Thomas Marchetti as Vice President of Investor Relations, effective immediately.
By Infinity Natural Resources, Inc. · Via Business Wire · February 18, 2026
NMG Awards Key Construction Contracts for the Phase-2 Matawinie Mine Ahead of FID
Nouveau Monde Graphite Inc. (“NMG” or the “Company”) (NYSE: NMG, TSX: NOU) is preparing for the construction of its Phase-2 Matawinie Mine – a major project of national interest as identified by the Government of Canada – via the procurement of key construction capacity, services, equipment and materials. Major contracts awarded over the past few months, with provisions for full execution upon the Company having reached a positive final investment decision (“FID”), represent over 50% of the project’s CAPEX and are within estimates of NMG’s updated feasibility study for the Phase-2 Matawinie Mine in accordance with National Instrument 43-101.
By Nouveau Monde Graphite Inc. · Via Business Wire · February 18, 2026
ActiveCampaign Backs Autonomous Marketing with Results Guarantee
ActiveCampaign, the autonomous marketing platform that has redefined its product for the AI era, announced a Results Guarantee for new customers. Unlike traditional money-back policies, ActiveCampaign's guarantee is focused on instant results, with a full refund available if they don't see them within their first month for any reason. While most platforms make businesses spend at least 30 days learning the ropes, ActiveCampaign improves marketing outcomes from the start.
By ActiveCampaign · Via Business Wire · February 18, 2026
Covetrus and MWI Animal Health to Merge
Cencora (NYSE: COR) and Covetrus, a global animal health technology and services company, today announced that they have entered into a definitive agreement under which Covetrus and MWI Animal Health (MWI) will merge, creating a combined company offering a comprehensive animal health platform.
By Cencora · Via Business Wire · February 18, 2026
KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the newly published International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema recommends EKTERLY® (sebetralstat) as a first-line therapy for the acute treatment of hereditary angioedema (HAE) attacks in adolescents aged 12 years and older.1
By KalVista Pharmaceuticals, Inc. · Via Business Wire · February 18, 2026
ProPetro Reports Financial Results for the Fourth Quarter and Full Year of 2025
ProPetro Holding Corp. ("ProPetro" or "the Company") (NYSE: PUMP) today announced financial and operational results for the fourth quarter and full year of 2025.
By ProPetro Holding Corp. · Via Business Wire · February 18, 2026
Seaport Therapeutics to Participate in Upcoming Investor Conferences in February and March
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that members of its management team will participate in the following upcoming investor conferences in February and March:
By Seaport Therapeutics · Via Business Wire · February 18, 2026
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
Radformation, a leading provider of intelligent automation solutions for radiation oncology, and Icon Group (Icon), a leading global integrated cancer care provider, today announced the initial deployment of ChartCheck Adaptive, Radformation’s Offline Adaptive Assessment solution, across 15 cancer centres in Australia. The rollout reflects the growing clinical value of automated adaptive assessment workflows within routine radiotherapy practice.
By Radformation · Via Business Wire · February 18, 2026
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call
National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter and fiscal 2025 financial results before the market opens on Wednesday, March 4, 2026, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company’s website at https://ir.nationalvision.com.
By National Vision Holdings, Inc. · Via Business Wire · February 18, 2026
Two Prime Registers as Commodities Trading Advisor with the CFTC and NFA
Two Prime Inc. (“Two Prime” or “the firm”), a provider of bitcoin financial services to institutional investors, today announced that it has registered with the Commodity Futures Trading Commission (CFTC) as a commodity trading advisor (CTA) and is a Member of the National Futures Association (NFA), allowing it to further extend its suite of services and expand its base of institutional clients.
By Two Prime Inc. · Via Business Wire · February 18, 2026
Palladyne AI Accelerates Commercial Push With Appointment of Matt Muta as President of Commercial Business
Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a U.S.-based defense and industrial technology company delivering embodied artificial intelligence software and autonomy solutions, today announced that long-time board member Matt Muta will transition from the Company’s Board of Directors to join Palladyne AI as President, Commercial and Industrial, effective March 2, 2026.
By Palladyne AI Corp. · Via Business Wire · February 18, 2026
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth quarter and full-year 2025 and provided guidance for 2026. For the quarter, revenue was $994.2 million, a decrease of 0.8% from $1,002.5 million in the fourth quarter of 2024.
Moody's Corporation Reports Results for Fourth Quarter and Full Year 2025
Moody's Corporation (NYSE: MCO) today announced results for the fourth quarter and full year 2025 and provided its outlook for full year 2026.
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, Feb. 24, 2026, at 3:30 p.m. ET, featuring Kevin M. Flanigan, MD, the Wolfe Foundation Endowed Chair in Neuromuscular Research at Nationwide Children’s Hospital and professor of pediatrics and neurology at The Ohio State University College of Medicine. Dr. Flanigan will join company management to discuss the unmet need and current treatment landscape for Duchenne muscular dystrophy (DMD). Interested participants may register here.
By Satellos Bioscience Inc. · Via Business Wire · February 18, 2026
Macrobond Recognized in G2’s 2026 Best Software Awards for Financial Services and New Software
Macrobond, the global platform for macroeconomic and financial data, today announced it has been named to G2’s 2026 Best Software Awards, earning recognition in the Best Financial Services Software Products and Best New Software Products categories. As the world’s largest and most trusted software marketplace, G2 reaches more than 100 million buyers annually. Its annual Best Software Awards rank the world’s leading software companies and products based on authentic, timely reviews from real users.
By Macrobond · Via Business Wire · February 18, 2026
monday.com Announces Participation in the Morgan Stanley Technology, Media & Telecom Conference
monday.com (NASDAQ: MNDY), the AI work platform that turns strategy into execution, at scale, today announced that members of its management team will participate in the Morgan Stanley Technology, Media & Telecom Conference on Monday, March 2nd, 2026 at 4:05pm PT.
By monday.com · Via Business Wire · February 18, 2026
Walker & Dunlop Announces 2026 Investor Day
Walker & Dunlop, Inc. announced today that it will host an Investor Day on Tuesday, March 10, 2026, beginning at 9:00 a.m. Eastern Time. The live webcast will provide an update on the company’s long-term growth strategy, with a specific focus on its five-year outlook, the Journey to ’30. The event will feature presentations and a Q&A session with members of Walker & Dunlop senior management.
By Walker & Dunlop, Inc. · Via Business Wire · February 18, 2026
Promega Honored as a U.S. Best-in-Class Employer by Gallagher
Promega Corporation has been recognized as a 2025 Best-in-Class Employer by Gallagher, a leading global insurance brokerage and benefits consulting firm. The designation, based on Gallagher's U.S. Benefits Strategy & Benchmarking Survey, honors employers that excel in employee wellbeing, benefits strategy and workplace engagement while maintaining cost-effective operations.
By Promega Corporation · Via Business Wire · February 18, 2026
WEBUY GLOBAL LTD. Launches Premium Travel Brand “Altitude,” Drives around US$400K in Opening Sales
Singapore, Feb. 18, 2026 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a technology-driven travel and lifestyle platform, today announced the successful launch of Altitude, its new AI-powered premium travel advisory brand. Altitude officially held its grand opening on January 26, 2026.
By Webuy Global Limited · Via GlobeNewswire · February 18, 2026
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
By Immunocore Holdings plc · Via GlobeNewswire · February 18, 2026
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Conference Call Scheduled for February 25, 2026, at 4:30 p.m. ET
By ADMA Biologics, Inc. · Via GlobeNewswire · February 18, 2026
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Administration (FDA) and advance its clinical pipeline.
By Aquestive Therapeutics, Inc. · Via GlobeNewswire · February 18, 2026